Ketamine Recruiting Phase 1 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03721900Ketamine for Major Depressive Disorder
NCT02165449Biomarkers of Fast Acting Therapies in Major Depression